Concepedia

Suresh G. Shelat

SG

Statistics

Publications

31

Citations

1.6K

H-Index

20

Active since

1998

Affiliations

University of Pennsylvania(Current)

Bristol-Myers Squibb (United States)

Children's Hospital of Philadelphia

Philadelphia University

Dana-Farber Cancer Institute

Suresh G. Shelat is an author at University of Pennsylvania specializing in medicine, hematology, and cancer immunotherapy.

Publications per year

1998–2021

31

Publications

31

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma

Meletios Α. Dimopoulos, Dominik Dytfeld, Sebastian Grosicki et al. · New England Journal of Medicine · 2018 · 535 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

NuRD mediates activating and repressive functions of GATA‐1 and FOG‐1 during blood development

Annarita Miccio, Yuhuan Wang, Hong Wei et al. · The EMBO Journal · 2009 · 154 citations · Full text

Life Sciences, Developmental Biology, Genetics +5

Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction

Michael L. Chen, T. Daniel Logan, Maryann L. Hochberg et al. · Blood · 2009 · 111 citations · Full text

Life Sciences, Cell Biology, Hematology +13

Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo

Suresh G. Shelat, Paula Smith, Jihui Ai et al. · Journal of Thrombosis and Haemostasis · 2006 · 94 citations · Full text

Life Sciences, Hematology, Molecular Biology +11

Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway

Manoj Kumar Kashyap, Deepak Kumar, Harrison Jones et al. · Oncotarget · 2015 · 87 citations · Full text

Medicine, Cell Biology, Oncology +17

1–5 of 31